ILKOS Therapeutic
Laval
About ILKOS Therapeutic
ILKOS Therapeutic is a biotechnology firm that observes differences in the lives of patients suffering from venous lower limb ulcers. The company's oral compound helps to treat venous lower limb ulcers, a disease that affects mainly older people.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $21.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2016)
- Website: ilkostherapeutic.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/ilkos-therapeutic-92774 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.